HIND Vyome Therapeutics: Multiplikator forward rega marang pendapatan

Vyome Holdings Inc (HIND) - logo korporat

The forward P/S ratio of Vyome Holdings Inc (HIND) reflects the sales valuation trend, with the indicator currently standing at 72.70. The Vyome Holdings Inc (HIND) team is recruiting immunology and weight loss experts through the expansion of R&D. Revenue is driven by the implementation of Lap-Band systems and new pharmaceuticals, although financial stability requires strict oversight due to asset restructuring.

HIND (Vyome Holdings) riwayat Rasio kapitalisasi pasar marang pendapatan mangsa ngarep saka 16.08.2025 nganti 18.11.2026

Ringkesan rincian data analitis Vyome Holdings Inc (HIND)

Analisis wiwitan perusahaan:ReShape Lifesciences (HIND)
Produk asli Vyome Therapeutics

For Vyome Holdings Inc (HIND), the potential of the DART platform in treating resistant infections determines the market value of future revenue streams, making a valuation based on forward P/S critically important. By analyzing the forward P/S dynamics, an investor can see the ratio of current market capitalization to projected sales, which allows for the identification of asset overvaluation or the discovery of an entry point when expected revenue is undervalued.

Pesaing wigati

Multiplikator Forward P/S ARGX (argenx.com)|BioNTech Group (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ABIVAX - Multiplikator Forward P/S|ADMA - Multiplikator Forward P/S|Protagonist (PTGX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Immunovant Inc|Rasio rega marang prakiraan pendapatan Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Rasio kapitalisasi marang dodolan sing dikarepake|Rasio rega marang prakiraan pendapatan Adaptive Biotechnologies Corp (ADPT)|Rasio rega marang prakiraan pendapatan CLDX (Celldex Therapeutics)|Rasio rega marang prakiraan pendapatan Aurinia Pharma AUPH|Rega forward marang dodolan BCRX|VERA: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PGEN (Intrexon)|Multiplikator forward rega marang pendapatan PHAR (Pharming)|NKTR (Nektar) - Rega forward marang dodolan|Multiplikator Forward P/S UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Rega mangsa ngarep marang pendapatan|IMNM - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Gossamer Bio Inc GOSS|KALV: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Septerna Pharma|PVLA (Pieris Corp) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan SVRA|Multiplikator Forward P/S RIGL|Multiplikator forward rega marang pendapatan AnaptysBio Corp ANAB|Astria Therapeutics Inc - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Multiplikator forward rega marang pendapatan|KYTX: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan VTYX (Ventyx Biosciences)|Rasio kapitalisasi marang dodolan sing dikarepake theratech.com|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc.)|Multiplikator Forward P/S Eledon Pharmaceuticals Inc. ELDN|AGEN: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan CLYM (Climb Bio, Inc)|ZURA: Multiplikator Forward P/S|aTyr Pharma, Inc. - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Adagene Inc.|IMA: Rega forward marang dodolan|Multiplikator Forward P/S STTK|Multiplikator forward rega marang pendapatan Equillium Bio EQ|Rasio rega marang prakiraan pendapatan Connect Biopharma CNTB|IMUX - Multiplikator forward rega marang pendapatan|ATRA - Rasio rega marang prakiraan pendapatan|InflaRx NV (IFRX) - Multiplikator forward rega marang pendapatan|XFOR (X4 Pharmaceuticals Inc.) - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Adicet Bio Inc. (ACET)|Rasio rega marang prakiraan pendapatan celularity.com|Multiplikator forward rega marang pendapatan inmunebio.com (INMB)|Rasio rega marang prakiraan pendapatan Barinthus Biotherapeutics PLC (BRNS)|Rasio kapitalisasi marang dodolan sing dikarepake Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Akari Therapeutics, Plc (AKTX)|ENLV: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Edesa|Rasio rega marang prakiraan pendapatan iBio, Inc.|Multiplikator forward rega marang pendapatan carismatx.com (CARM)|Multiplikator Forward P/S XTLB|Multiplikator forward rega marang pendapatan Bolt Bio BOLT|Multiplikator Forward P/S HCWB (HCW Biologics)|APVO: Kapitalisasi marang prakiraan pendapatan|AIM - Rasio rega marang prakiraan pendapatan|ADTX - Multiplikator Forward P/S|GRI Bio (GRI) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan XORTX Therapeutics|Rasio rega marang prakiraan pendapatan Revelation Bio|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Indaptus Therapeutics, Inc. INDP|Rasio rega marang prakiraan pendapatan BiondVax Pharmaceuticals (SCNI)|Multiplikator forward rega marang pendapatan CalciMedica CALI|Rasio rega marang prakiraan pendapatan Affimed AFMD|ALLK - Multiplikator forward rega marang pendapatan|HOOKIPA Pharma, Inc. - Multiplikator Forward P/S|Rega forward marang dodolan IGMS (igmbio.com)|ITOS (iTeos Therapeutics, Inc.) - Multiplikator forward rega marang pendapatan|Ocean Biomedical Corp (OCEA) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Multiplikator Forward P/S thirdharmonicbio.com